STAT+: Pharmalittle: We’re reading about a Novo setback, support for Replimune’s melanoma drug, and more
Source ↗
👁 1
💬 0
And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still taking shape, but we plan on promenading with the official mascots, catching up on our reading, and manicuring the Pharmalot campus. We also hope to hold still another listening party, where the rotation will likely feature this, this, this, this and this. And what about you? If the weather cooperates, the possibili
Comments (0)